A PHASE II, RANDOMIZED STUDY OF ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) AND TRASTUZUMAB IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN (XELOX) IN PATIENTS WITH HER2 POSITIVE LOCALLY ADVANCED RESECTABLE GASTRIC CANCER OR ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION (GEJ)
| Title | A PHASE II, RANDOMIZED STUDY OF ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) AND TRASTUZUMAB IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN (XELOX) IN PATIENTS WITH HER2 POSITIVE LOCALLY ADVANCED RESECTABLE GASTRIC CANCER OR ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION (GEJ) |
|---|---|
| Description | This is a phase II,multicenter,randomized,open-label study designed to evaluate the efficacyand safety of perioperative trastuzumab+XELOX with / without atezolizumab in patients eligible for surgery with locally advanced HER2-positive gastric cancer or adenocarcinoma of GEJ. Publish the data of Copy number of HER2 in circulating tumor DNA,no sequencing involved,and Her2 fish test data. |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA017352 |
| Release Date | 2024-09-30 |
| Submitter | lin shen (linshenpku@163.com) |
| Organization | Beijing Cancer Hospital |
| Submission Date | 2024-06-19 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX006706-01 | Copy number of HER2 in ctDNA,Her2 fish test data | 42 | Other Type of Genomic Data | 325.3 KB | xlsx | 0 | Controlled |